San Francisco-based uBiome, which makes a direct-to-consumer microbial genomic testing kit, has closed on a $22 million Series B funding round, led by 8VC with additional funding from Slow Ventures, Stanford’s StartX Fund and various angel investors. uBiome, a San Franscisco-based company that makes a direct-to-consumer microbial genomic testing kit, has raised $22m in a Series B funding round from 8VC, Slow Ventures, Stanford's StartX Fund and other angel investors. The startup is developing an app to help people identify microbes they might be exposed to, such as those found on their skin or in the air around them. By making gut health testing faster and easier, uBiome will unquestionably have a massive impact," said Joe Lonsdale, founding partner at 8VC.
uBiome, a San Franscisco-based company that makes a direct-to-consumer microbial genomic testing kit, has raised $22m in a Series B funding round from 8VC, Slow Ventures, Stanford's StartX Fund and other angel investors. The startup is developing an app to help people identify microbes they might be exposed to, such as those found on their skin or in the air around them. By making gut health testing faster and easier, uBiome will unquestionably have a massive impact," said Joe Lonsdale, founding partner at 8VC.